Meghna Samant

Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA

Ian E. Krop, Nancy U. Lin, Kimberly Blackwell et al. · Annals of Oncology · 2014 · 402 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer

José Baselga, Gail D. Lewis Phillips, Sunil Verma et al. · Clinical Cancer Research · 2016 · 226 citations · Full text

Medicine, Oncology, Pharmacology +17

Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non–Small-Cell Lung Cancer Treated With Carboplatin and Paclitaxel Plus Bevacizumab

Alan B. Sandler, Joan H. Schiller, Robert J. Gray et al. · Journal of Clinical Oncology · 2009 · 155 citations · Full text

Medicine, Oncology, Radiology +12

Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: An Integrated Safety Analysis

Véronique Dièras, Nadia Harbeck, G. Thomas Budd et al. · Journal of Clinical Oncology · 2014 · 127 citations · Full text

Medicine, Oncology, Pharmacology +17

Corticosteroid Use in Patients with Glioblastoma at First or Second Relapse Treated with Bevacizumab in the BRAIN Study

James J. Vredenburgh, Timothy F. Cloughesy, Meghna Samant et al. · The Oncologist · 2010 · 113 citations · Full text

Medicine, Oncology, Pharmacotherapy +16